Related Experiment Videos
[Cardiovascular disease after kidney transplantation]
J Hjelmesaeth1, K Midtvedt, S Aakhus
1Medisinsk avdeling Vestfold sentralsykehus, Tønsberg.
Summary
Cardiovascular disease is a leading cause of death in Norwegian renal transplant recipients. While common risk factors exist, other factors like hyperhomocysteinemia and advanced glycosylated end products contribute to high cardiovascular risk.
Area of Science:
- Nephrology
- Cardiology
- Immunology
Context:
- Renal transplant recipients exhibit a high prevalence of cardiovascular disease (CVD).
- CVD accounts for a significant majority of deaths in this patient population.
- Traditional CVD risk factors are common but insufficient to explain the elevated morbidity and mortality.
Purpose:
- To review the prevalence and contributing factors of cardiovascular disease in Norwegian renal transplant recipients.
- To discuss the limitations of current risk factor assessment in this population.
- To provide guidance on managing cardiovascular risk in renal transplant patients.
Summary:
- Atherosclerotic disease and left ventricular hypertrophy are prevalent pre-transplant.
- Hyperhomocysteinemia, advanced glycosylated end products, and immunosuppressants may accelerate atherosclerosis.
- Lipid-lowering therapy decisions should currently rely on non-transplant patient data.
Impact:
- Highlights the significant cardiovascular burden in renal transplant recipients.
- Emphasizes the need for comprehensive risk assessment beyond traditional factors.
- Informs clinical practice regarding cardiovascular risk management in this vulnerable group.